ZINC4658562 (Dla)
| Added | Available | Since | Mwt | logP | Heavy Atoms | Tranche | Download |
|---|---|---|---|---|---|---|---|
| 2005-12-22 | In-Stock | 2015-08-07 | 90.078 | -0.548 | 6 | ABAA |
|
Find Decoys
Available 3D Representations
| pH range | Net charge |
H-bond donors |
H-bond acceptors |
tPSA Ų | Rotatable bonds |
Apolar desolvationkcal/mol |
Polar desolvationkcal/mol |
Download |
|---|---|---|---|---|---|---|---|---|
| Reference | -1 | 1 | 3 | 60 | 1 | 0.33 | -46.53 |
|
419 Items Total
Vendors (61 Total)
-
- 1614
- 1722
- 26499
- 8023
-
- CP26143
-
- PI-14769
-
- CUR-0100772
-
- DB-023012
-
- BB0294834
-
- SCA04248
-
- BBS-00028838
-
- SC-15837
- SC-15841
- SC-18033
- SC-18578
- SC-19308
- SC-20005
- SC-25623
- SC-46260
- SC-75139
- SC-86055
-
- SC-15837
- SC-15841
- SC-18033
- SC-18578
- SC-19308
- SC-20005
- SC-25623
- SC-46260
- SC-75139
- SC-86055
-
- 50A219912
- 50A430187
- 50C117840
-
- AM013971
- HE065661
- HE390252
- IN016291
- OR010909
- OR019939
- OR022711
- OR031387
- OR031917
- OR031922
- OR031923
- OR031926
- OR034131
- OR034428
- OR035460
- OR036021
- OR036301
- OR036302
- OR036344
- OR037409
- OR037530
- OR038389
- OR039192
- OR039396
- OR040126
- OR040285
- OR040633
- OR040961
- OR042796
- OR045331
- OR049127
- OR049530
- OR053582
- OR056450
- OR056563
- OR056812
- OR057175
- OR057468
- OR058360
- OR058405
- OR058679
- OR061123
- OR061723
- OR064690
- OR065388
- OR065391
- OR066301
- OR066998
- OR067407
- OR068610
- OR071010
- OR071313
- OR071522
- OR071648
- OR072143
- OR194786
- OR194807
- OR195501
- OR203762
- OR209370
- OR211854
- OR216153
- OR217542
- OR222518
- OR223030
- OR226358
- OR227165
- OR227166
- OR227167
- OR227496
- OR228869
- OR229754
- OR230597
- OR236163
- OR236166
- OR236740
- OR238581
- OR240464
- OR249756
- OR252071
- OR252663
- OR254761
- OR256570
- OR256602
- OR260257
- OR260325
- OR262918
- OR264803
- OR266443
- OR275728
- OR277125
- OR277349
- OR286183
- OR287592
- OR287593
- OR290680
- OR292158
- OR293419
- OR293910
- OR294936
- OR298928
- OR313912
- OR314097
- OR315034
- OR315035
- OR321890
- OR328073
- OR329822
- OR331373
- OR333061
- OR340823
- OR342356
- OR342875
- OR343164
- OR343279
- OR344466
- OR344467
- OR353877
- OR376273
- OR381106
- OR382769
- OR382827
-
- LN00194556
- LN00194811
- LN00196809
- LN00201968
- LN00220435
- LN00225569
- LN00227123
- LN01248361
- LN01287241
- LN01343795
- LN01357219
- LN01360215
- LN01808814
- LN02144946
- LN02184209
- LN02184287
-
- SC-15837
- SC-15841
- SC-18033
- SC-18578
- SC-46260
102 Items Total
Annotated Catalogs (43 Total)
-
- Spectrum-13-E-9
-
- 01506202
-
- 01506202
-
- 01506202
-
- BIE035863
- BIE140562
-
- 867-55-0
-
- D-LACTATE
-
- DLA
- LAC
-
- SW00046
-
- UNPD29370
- UNPD70838
Activities based on ChEMBL 20
There is no known activity for this compound.
Run SEA
SEA Predictions based on ChEMBL 20
| Gene | Description | Target Class | P-Value | Max Tc |
|---|---|---|---|---|
| TSPAN17 | Tetraspanin | membrane receptor / Membrane-other | 0 | 40 |
Find All
Interesting Analogs
Substance Rings
This compound has no patterns of concern (or they have not yet been computed).
Molecular Patterns (Warnings, etc.)
References
This substance is not reported in any publications per ChEMBL.
View All 148 Clinical Trials
| Trial ID | Title | Status | Phase | Start Date | Condition(s) | Drug(s) |
|---|---|---|---|---|---|---|
| NCT02240407 | Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease | Not yet recruiting | Phase 1 | Jan 2016 |
Pompe Disease
|
Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
Rapamycin
Lactated Ringer's
Rituxan
Diphenhydramine
Acetaminophen
Lidocaine
|
| NCT02048943 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | Withdrawn | Phase 1 | Mar 2015 |
Duct Cell Adenocarcinoma of the Pancreas
Unspecified Adult Solid Tumor, Protocol Specific
Stage III Pancreatic Cancer
Recurrent Pancreatic Cancer
Stage IV Pancreatic Cancer
|
dovitinib lactate
gemcitabine hydrochloride
paclitaxel albumin-stabilized nanoparticle formulation
pharmacological study
laboratory biomarker analysis
|
| NCT02327611 | CUstodiol Versus RInger: whaT Is the Best Agent? | Recruiting | Phase 4 | Feb 2015 |
Thoracoabdominal Aortic Aneurysms
|
Custodiol
Enriched Ringer's lactate solution
|
| NCT02349516 | Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME) | Not yet recruiting | Phase 2 | Feb 2015 |
Diabetic Retinopathy
|
Squalamine Lactate Ophthalmic Solution 0.2%
|
| NCT01313533 | Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes | Not yet recruiting | Phase 1/Phase 2 | Jan 2015 |
Atherosclerosis
|
Polyarginine
Lactated Ringers Solution
|
Additional Identifiers (Synonyms/CAS Numbers/etc.)
- CAS Numbers
- ATC Code(s)
- WHO Name(s)
- Molecule Names
-
- AMMONIUM LACTATE
- CALCIUM LACTATE
- D-LACTIC ACID
- LACTIC ACID
- POTASSIUM LACTATE
- SODIUM LACTATE
- Synonyms
-
- Lactic Acid
- Ammonium lactate
- D-Lactic acid
- D-Lactic Acid
- Ammonium lactate
- Lactic acid ammonium salt
- D-2-Hydroxypropanoate
- D-2-Hydroxypropanoic acid
- D-2-Hydroxypropionate
- D-2-Hydroxypropionic acid
- delta-2-Hydroxypropanoate
- delta-2-Hydroxypropanoic acid
- delta-2-Hydroxypropionate
- delta-2-Hydroxypropionic acid
- delta-Lactate
- delta-(-)-Lactate
- delta-(-)-Lactic acid
- delta-Lactic acid
- DLA
- D-Lactate
- D-(-)-Lactate
- D-(-)-Lactic acid
- (-)-Lactate
- (-)-Lactic acid
- L-(+)-Lactate
- L-Lactic acid
- Propel
- (R)-2-Hydroxypropanoate
- (R)-2-Hydroxypropanoic acid
- (R)-2-Hydroxypropionate
- (R)-2-Hydroxypropionic acid
- (R)-a-Hydroxypropionate
- (R)-a-Hydroxypropionic acid
- (R)-alpha-Hydroxypropionate
- (R)-alpha-Hydroxypropionic acid
- (R)-Lactate
- (R)-(-)-Lactate
- (R)-(-)-Lactic acid
- (R)-Lactic acid
- Tisulac
- Ammonium Lactate
- Lac-hydrin
- Laclotion
- Ammonium (+-)-lactate